Group A

(IV Cefoxitin + pocipro)

Group B

(Oral FT)

p < 0.05

Infectious, n (%)

7 (2.9)

4 (2.2)

0.64

Prostatitis

7 (2.9)

4 (2.2)

0.64

Orchiepididymitis

0

0

1.00

Sepsis

4 (1.66)

0

0.14

Non-Infectious, n (%)

16 (6.6)

9 (4.9)

0.24

Hematuria

7 (2.9)

2 (1.09)

0.31

Rectal bleeding

0

1 (0.54)

0.43

Perineal pain

1 (0.41)

1 (0.54)

1.00

Acute urinary retention

3 (1.24)

5 (2.72)

0.30

Hematospermia

1 (0.41)

0

1.00

Hospitalization

4 (1.66)

2 (1.09)

0.70